Mayne Pharma Group Ltd has released a press release.
AGM presentation and business and trading update
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
In the deck
Story so far
Earlier from Mayne Pharma
- Return of Capital - MYX
- Dividend/Distribution - MYX
- Mayne Pharma capital management update
- Mayne Pharma completes sale of Metrics Contract Services
- Mayne Pharma - appointment of chief executive officer and Managing Director
Later from Mayne Pharma
- MYX signs license agreement for womens health products
- MYX completes TherapeuticsMD product licensing transaction
- Mayne Pharma provides update on capital management timeline
- Mayne Pharma and Mithra announce US launch of HALOETTE, a generic version of NUVARING
- Mayne Pharma to restate US dermatology net revenue for FY22
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma